Hsp90 and co-chaperones twist the functions of diverse client proteins.
about
Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjectsAdvances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancersmTOR: An attractive therapeutic target for osteosarcoma?Distinct roles of molecular chaperones HSP90α and HSP90β in the biogenesis of KCNQ4 channelsApproaches for defining the Hsp90-dependent proteome.Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasisThe Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistanceOxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer CellsSgt1 acts via an LKB1/AMPK pathway to establish cortical polarity in larval neuroblasts.Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesionsThe Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative DiseasesIdentification of in vivo HSP90-interacting proteins reveals modularity of HSP90 complexes is dependent on the environment in psychrophilic bacteria.An Hsp90 co-chaperone protein in yeast is functionally replaced by site-specific posttranslational modification in humansDestabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML)Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directionsHsp90 is required for transfer of the cholera toxin A1 subunit from the endoplasmic reticulum to the cytosol.Thermodynamics of aryl-dihydroxyphenyl-thiadiazole binding to human Hsp90Heat shock protein 90 in Alzheimer's diseaseSuberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.An increase in integrin-linked kinase non-canonically confers NF-κB-mediated growth advantages to gastric cancer cells by activating ERK1/2.A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies.Heat shock protein 90-mediated inactivation of nuclear factor-κB switches autophagy to apoptosis through becn1 transcriptional inhibition in selenite-induced NB4 cells.Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy.17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2Assessment and reconstruction of novel HSP90 genes: duplications, gains and losses in fungal and animal lineages.Topically applied Hsp90 inhibitor 17AAG inhibits UVR-induced cutaneous squamous cell carcinomasHSP90 functions in the circadian clock through stabilization of the client F-box protein ZEITLUPE.Molecular chaperone Hsp90 is a therapeutic target for norovirusesExpression and purification of Src-family kinases for solution NMR studies.Temperature desynchronizes sugar and organic acid metabolism in ripening grapevine fruits and remodels their transcriptomeCorrelation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancerNovel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90Heat shock protein 90 in plants: molecular mechanisms and roles in stress responses.ER stress stimulates production of the key antimicrobial peptide, cathelicidin, by forming a previously unidentified intracellular S1P signaling complexHSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.Developmental mechanisms underlying variable, invariant and plastic phenotypes.Clients Place Unique Functional Constraints on Hsp90.Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies.Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.
P2860
Q24600166-8F00F66D-1C5D-4A9D-8EDC-D5B60DFE405EQ27022514-BBDD3C83-B5B3-4EF3-A5FA-9AE8F01DA676Q28078490-C757FF16-0D62-4D18-B980-15902C765CCCQ28115218-D9387E4A-911E-4B43-A1C6-D770D2DD1117Q28247643-6BD918D7-0D42-4D3E-BFF6-305888F46F08Q28249103-AB60ACF7-2668-4A04-92C2-0F4E0A688E3BQ28286034-7CBD0603-0236-4649-91B8-10F244F3D79CQ28483590-2E76FBD5-0DDB-44E3-8BD7-1DCF9DB74DEFQ28550200-2B37F41A-D4A9-4951-AEB7-656019B4D179Q30577652-E9F563BB-CDE3-414B-BD07-FC3C4033AD84Q33625453-9968565E-A324-47AF-A78C-4BB37D5A88B4Q33692255-F13D3C43-14F5-4E1F-90B2-FB32CD91E3EBQ33709006-4131BCE4-DCEB-47DC-8436-34872217C0B9Q33761192-04113B1A-3471-4AEC-938A-DBB9C05ECC01Q34082540-6251AC98-1A23-40D2-94BE-454A443261E1Q34164027-C95F78F3-8A30-44B5-811A-D2FE1CDAF456Q34181280-9089954A-5D95-45F8-BFC5-F7F731CDA38BQ34288879-6093989E-0904-4D6C-9A19-17C4ADE7B569Q34413279-6FEDD6D7-6ADD-40F2-8C19-5C90D669AB6EQ34629026-7F2637A4-9E7B-465F-A67B-EFAE0C495EF1Q34629975-1FE81E91-706B-4E9F-9A5C-4B7A77B49429Q34636437-CB1AB765-0133-42FE-9E7A-E4F178E8B8B3Q34803115-5428354E-ED15-4FD1-BF3D-4A29CF05DB59Q34915636-75577A95-A7AD-42AC-AAF9-B0AF73523C12Q34989144-E8C86CDC-BFD6-4817-A04B-E137F74EEC53Q34996975-86D22FBF-1BC8-4749-9727-2F8D66405E0EQ35196261-FA0422A8-E4BB-49EF-B3CB-39774984A5CCQ35289404-F7913D40-612E-409C-A26F-4F2233D5AB6DQ35760516-E843EFCD-358C-4A41-ABD0-2191C9EC08E1Q35835262-21F0332D-E64A-4EC7-A203-B90224CE89E0Q36083151-303790D1-C524-4E71-BBF4-9B51000C98A9Q36378835-4B8D2155-233B-491F-A219-3FF0AF96343DQ36511107-180C3299-246C-4499-9E2F-077CC9891B14Q36538289-2F78F71F-B0EF-4D4B-A036-8187062176EFQ36684780-CB003039-226B-4693-8E6D-4781B2B19248Q36729440-1A2836D9-ED65-4D05-968E-25EE546EA358Q36837933-46CED401-5B23-44FC-A733-FD7B78D8B2E6Q37059124-3C5FB2F2-556A-4694-AF7B-B1D1DE0616F8Q37235682-B6B2985A-FA72-41D4-B837-702770814E14Q37622446-65CB2A5A-0C95-4DEC-909E-4E388EE97C98
P2860
Hsp90 and co-chaperones twist the functions of diverse client proteins.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hsp90 and co-chaperones twist the functions of diverse client proteins.
@ast
Hsp90 and co-chaperones twist the functions of diverse client proteins.
@en
type
label
Hsp90 and co-chaperones twist the functions of diverse client proteins.
@ast
Hsp90 and co-chaperones twist the functions of diverse client proteins.
@en
prefLabel
Hsp90 and co-chaperones twist the functions of diverse client proteins.
@ast
Hsp90 and co-chaperones twist the functions of diverse client proteins.
@en
P2860
P356
P1433
P1476
Hsp90 and co-chaperones twist the functions of diverse client proteins.
@en
P2093
Abbey Zuehlke
Jill L Johnson
P2860
P304
P356
10.1002/BIP.21292
P577
2010-03-01T00:00:00Z